This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08040/identifier/pubchem-compound/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08040/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08040/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08040/identifier/chemspider/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08040/identifier/pdb/

Statements

Subject Item
n2:DB08040
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08040 n13:DB08040
dcterms:title
N-[(2R)-2-benzyl-4-(hydroxyamino)-4-oxobutanoyl]-L-alanine
adms:identifier
n8:DB08040 n9:KEL n10:110501 n11:123982 n12:99444511
n3:IUPAC-Name
n4:271B581B-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5821-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5820-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B581D-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B581E-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B581F-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5819-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B581A-363D-11E5-9242-09173F13E4C5 n4:271B5817-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5818-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5827-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5828-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5822-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5823-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5825-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5824-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5826-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B582D-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B582F-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5830-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B582C-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B582B-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B582E-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B581C-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5829-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B582A-363D-11E5-9242-09173F13E4C5